|
Volumn 27, Issue 5, 2004, Pages 1236-1237
|
Soluble CD40L in Young Type 1 Diabetic Individuals Without Clinical Microvascular and Macrovascular Complications
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ABCIXIMAB;
ANTIHYPERTENSIVE AGENT;
ANTILIPEMIC AGENT;
CD40 LIGAND;
HEMOGLOBIN A1C;
ADULT;
ARTICLE;
ATHEROSCLEROSIS;
BLOOD PRESSURE MEASUREMENT;
BODY MASS;
CLINICAL ARTICLE;
CONTROLLED STUDY;
DIABETES CONTROL;
DIABETIC ANGIOPATHY;
ENZYME LINKED IMMUNOSORBENT ASSAY;
FEMALE;
HIGH RISK PATIENT;
HUMAN;
IN VITRO STUDY;
IN VIVO STUDY;
INFLAMMATION;
INSULIN DEPENDENT DIABETES MELLITUS;
LIPID BLOOD LEVEL;
MALE;
MICROANGIOPATHY;
PROTEIN DETERMINATION;
PROTEIN EXPRESSION;
PROTEIN LOCALIZATION;
PROTEIN PROTEIN INTERACTION;
PROTEIN SECRETION;
THROMBOSIS;
ADULT;
BIOLOGICAL MARKERS;
CD40 LIGAND;
DIABETES MELLITUS, TYPE 1;
FEMALE;
HEMOGLOBIN A, GLYCOSYLATED;
HUMANS;
MALE;
PILOT PROJECTS;
REFERENCE VALUES;
|
EID: 2342565242
PISSN: 01495992
EISSN: None
Source Type: Journal
DOI: 10.2337/diacare.27.5.1236 Document Type: Article |
Times cited : (12)
|
References (4)
|